In Preparation for Biosimilar "Switch" Policy: How to Mitigate the Nocebo Effect
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY(2022)
关键词
biosimilars, biologics, nocebo, infliximab, etanercept, adalimumab
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
JOURNAL OF CUTANEOUS MEDICINE AND SURGERY(2022)